CANDOL
DEAD

Serial Number

87117671

Owner

Senzer Limited

Filing Date

Jul 27, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CANDOL Trademark

Serial Number: 87117671 • Registration: 5353118

CANDOL is a trademark filed by Senzer Limited on July 27, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Senzer Limited (6 trademarks)

2 Angel Square

Entity Type: 99

Trademark Details

Filing Date

July 27, 2016

Registration Date

December 12, 2017

Published for Opposition

September 26, 2017

Cancellation Date

June 28, 2024

Goods & Services

Medical preparations in the nature of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, glaucoma, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and hepatic, renal, intestinal, autoimmune, metabolic, neurological, dermatological and cardiovascular disorders; sanitary preparations for medical purposes; vaccines; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for injection for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the form of liquid medications, tablets, powders, capsules, inhalers, nasal sprays, orally disintegrating tablets, mouthwashes, that facilitate the delivery of pharmaceutical preparations; medicated transdermal drug delivery patches for use in the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; none of the aforementioned containing natural borage oil, being nutritional supplements, medicinal ointments, capsules for medicines, medicinal oils, dermatological preparations or for use in dermatology or in dietetics

Inhalers for medical purposes; filters for inhalers for medical purposes; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; non-medicated transdermal drug delivery patches; medical apparatus and instruments for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; medical apparatus and instruments for use in surgery

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 28, 2024 C8..
WITHDRAWAL OF ATTORNEY GRANTED
Sep 14, 2023 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Sep 14, 2023 WOAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 12, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 12, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2017 CRFA
ASSIGNED TO LIE
Aug 16, 2017 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 24, 2017 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 27, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 27, 2017 GNSL
SUSPENSION LETTER WRITTEN
Apr 27, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2016 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2016 NWOS
NEW APPLICATION ENTERED
Jul 30, 2016 NWAP